Major
Share Cancellation
Dongkoo Bio & Pharma will cancel 822,134 treasury common shares, worth KRW 3.0 billion, on November 10, 2026.
DongKoo Bio & Pharma Co., Ltd. Disclosures
006620 · KOSDAQ · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from DongKoo Bio & Pharma Co., Ltd..